2012
DOI: 10.1074/jbc.m111.337477
|View full text |Cite
|
Sign up to set email alerts
|

Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B Cells

Abstract: Background: Human B cells respond to Toll-like receptor (TLR) 9 stimulation by cytokine production. Results: A rare, novel TLR9 allele fails to activate NF-B in HEK293 cells. Heterozygous carrier B cells show defective IL-6 and IL-10 production. Conclusion: Heterozygosity for this TLR9 allele modifies CpG oligonucleotide responsiveness. Significance: This is the first analysis of human TLR9 variants in primary cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…DNA was isolated from blood samples of PTB patients (N=244) and contact controls (n=85) treated at the Section of Pulmology, Department of Internal Medicine, Clinical Hospital Centre Rijeka, Rijeka and Hospital for Lung Diseases “Jordanovac”, University Hospital Center “Zagreb”, and healthy blood donors (n=924) collected at Departments of Transfusion Medicine in Rijeka and in Zagreb, Croatia, as previously described36,37. DNA samples from the blood of additional 194 PTB patients, treated in Hospital for Lung Disease “Jordanovac”, University Hospital Center “Zagreb”, Croatia, were isolated at deCODE, Reykjavik, Iceland.…”
Section: Methodsmentioning
confidence: 99%
“…DNA was isolated from blood samples of PTB patients (N=244) and contact controls (n=85) treated at the Section of Pulmology, Department of Internal Medicine, Clinical Hospital Centre Rijeka, Rijeka and Hospital for Lung Diseases “Jordanovac”, University Hospital Center “Zagreb”, and healthy blood donors (n=924) collected at Departments of Transfusion Medicine in Rijeka and in Zagreb, Croatia, as previously described36,37. DNA samples from the blood of additional 194 PTB patients, treated in Hospital for Lung Disease “Jordanovac”, University Hospital Center “Zagreb”, Croatia, were isolated at deCODE, Reykjavik, Iceland.…”
Section: Methodsmentioning
confidence: 99%